Virus-like particle vaccines: immunology and formulation for clinical translation

Introduction: Virus-like particle (VLP) vaccines face significant challenges in their translation from laboratory models, to routine clinical administration. While some VLP vaccines thrive and are readily adopted into the vaccination schedule, others are restrained by regulatory obstacles, proprieta...

Full description

Bibliographic Details

Published in:	Expert Review of Vaccines
Main Authors:	Braeden Donaldson, Zabeen Lateef, Greg F. Walker, Sarah L. Young, Vernon K. Ward
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-09-01
Subjects:	clinical translation formulation immunology vaccine virus-like particle vlp
Online Access:	http://dx.doi.org/10.1080/14760584.2018.1516552